A Pilot Study of Rosiglitazone in the Treatment of GH Secreting Pituitary Adenomas

NCT03309319 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Pituitary Tumor

Interventions

DRUG: Rosiglitazone

Sponsor

Zhaoyun Zhang